ArticleThe Journal of international medical research2020

Cetuximab versus bevacizumab maintenance following prior 8-cycle modified FOLFOXIRI plus cetuximab in Asian postmenopausal women with treatment-naive KRAS and BRAF wild-type metastatic colorectal cancer.

Baomin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.